News
Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration ...
2h
InvestorsHub on MSNGSK shares rise after FDA grants priority review for oral gonorrhea antibioticGSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...
GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...
Here are two beaten-down stocks that long-term investors might want to consider buying on the dip and holding for several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results